ClinicalTrials.Veeva

Menu

D Mannose for Prevention and Treatment of RUTIs (mannoseRUTIs)

I

IRCCS Policlinico S. Matteo

Status

Completed

Conditions

Antibiotic Resistance
Antibiotic Prophylaxis
Recurrent Urinary Tract Infections

Treatments

Other: systematic review

Study type

Observational

Funder types

Other

Identifiers

NCT03790254
ReviewUTIs

Details and patient eligibility

About

The aim of this review is to address clinical reliability, efficacy and safety of long-term treatment with oral D Mannose for the prevention of recurrent urinary tract infections (RUTIs) in females.

Full description

A comprehensive systematic MEDLINE, Embase, Cochrane search was performed for English language reports published before December 2018 using the term "recurrent urinary tract infections and d mannose." We searched Medline, Embase, and the Cochrane Register of Controlled Trials since January 2010 to December 2018. Eligible studies did not include non-oral therapy, local (vaginal) treatment in women with RUTIs.

Study eligibility criteria- We identified eligible original articles. The heterogeneity of the available studies, their different rationale and aim, the assumption of d mannose for prophylaxis or treatment of recurrent UTIs need to be taken into account.

Enrollment

500 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

recurrent urinary tract infections (RUTIs)

Exclusion criteria

Upper urinary tract infections, severe clinical symptoms, fever > 37,5 with lumbar pain

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems